REGENERON PHARMACEUTICALS, INC.
Position in NTLA — Intellia Therapeutics, Inc.
CIK 872589
TARRYTOWN, NY
Position in NTLA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$47,472,395
+$14,182,470 QoQ
Shares Held
3,702,995
0.0% QoQ
Ownership
2.65%
of shares outstanding
% of Portfolio
100.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026REGENERON PHARMACEUTICALS, INC. holds $47,472,395 across 1 Biotechnology name. NTLA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTLA |
Intellia Therapeutics, Inc.
This page
|
3,702,995 | $47,472,395 |
All Filings in NTLA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,472,395 | 3,702,995 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $33,289,925 | 3,702,995 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $63,950,723 | 3,702,995 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $34,734,093 | 3,702,995 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $26,328,294 | 3,702,995 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $43,176,921 | 3,702,995 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||